Sphera Funds Management »

IsoRay shares owned by Sphera Funds Management

Quarter-by-quarter ownership of IsoRay (CATX) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in IsoRay

Tip: Access up to 7 years of quarterly data

All positions including IsoRay held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IsoRay by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $10k 26k 0.40

More positions owned by Sphera Funds Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Sanofi Sponsored Adr (SNY)
Cytokinetics Com New (CYTK)
NOVA MEASURING Instruments L (NVMI)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Tower Semiconductor Shs New (TSEM)
Nice Sponsored Adr (NICE)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Astrazeneca Sponsored Adr (AZN)
Biogen Idec (BIIB)
Bridgebio Pharma (BBIO)

View all positions for Sphera Funds Management

Top funds holding IsoRay

Vanguard Group
Baker Bros. Advisors
AlphaCentric Advisors
Osterweis Capital Management
HighTower Advisors
Perkins Capital Management
Taylor & Morgan Wealth Management
Portland Investment Counsel
Creative Planning
Wealth Effects
Charles Schwab Investment Management
Mariner Wealth Advisors
Bank of New York Mellon
Commonwealth Equity Services
ADAR1 Capital Management

View all funds holding IsoRay